Xeris Biopharma (XERS) Short Interest Ratio & Short Volume $3.46 +0.07 (+2.06%) (As of 05:42 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Xeris Biopharma Short Interest DataXeris Biopharma (XERS) has a short interest of 9.52 million shares. This marks a -3.94% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.1, indicating that it would take 6.1 days of the average trading volume of 1.70 million shares to cover all short positions.Current Short Interest9,520,000 sharesPrevious Short Interest9,910,000 sharesChange Vs. Previous Month-3.94%Dollar Volume Sold Short$31.23 millionShort Interest Ratio6.1 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares149,081,000 sharesPercentage of Shares Shorted6.39%Today's Trading Volume1,314,605 sharesAverage Trading Volume1,704,862 sharesToday's Volume Vs. Average77% Short Selling Xeris Biopharma? Sign up to receive the latest short interest report for Xeris Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartXERS Short Interest Over TimeXERS Days to Cover Over TimeXERS Percentage of Float Shorted Over Time Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Xeris Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/20249,520,000 shares $31.23 million -3.9%N/A6.1 $3.28 11/30/20249,910,000 shares $32.50 million -2.4%N/A6.1 $3.28 11/15/202410,150,000 shares $29.64 million -10.7%N/A6.4 $2.92 10/31/202411,370,000 shares $36.61 million -1.7%N/A7.2 $3.22 10/15/202411,570,000 shares $34.94 million +4.3%N/A7.7 $3.02 9/30/202411,090,000 shares $31.61 million +0.8%N/A7.2 $2.85 Get the Latest News and Ratings for XERS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xeris Biopharma and its competitors with MarketBeat's FREE daily newsletter. 9/15/202411,000,000 shares $31.68 million +2.7%N/A7.1 $2.88 8/31/202410,710,000 shares $30.10 million -0.9%N/A7.6 $2.81 8/15/202410,810,000 shares $28.32 million -3.7%N/A7.5 $2.62 7/31/202411,220,000 shares $27.83 million -1.7%N/A7.9 $2.48 7/15/202411,410,000 shares $28.30 million +3.7%N/A8.7 $2.48 6/30/202411,000,000 shares $24.75 million -0.8%N/A8.2 $2.25 6/15/202411,088,000 shares $24.39 million -2.1%N/A7.9 $2.20 5/31/202411,330,000 shares $25.55 million +5.0%N/A7.3 $2.26 5/15/202410,790,000 shares $21.36 million +11.9%N/A6.4 $1.98 4/30/20249,640,000 shares $16.87 million +7.8%N/A5.2 $1.75 4/15/20248,940,000 shares $16.54 million -0.5%N/A4.8 $1.85 3/31/20248,980,000 shares $19.85 million -2.8%N/A4 $2.21 3/15/20249,240,000 shares $20.61 million -4.2%N/A4 $2.23 2/29/20249,640,000 shares $29.64 million +2.3%N/A4.2 $3.08 2/15/20249,420,000 shares $30.24 million +0.2%N/A4.6 $3.21 1/31/20249,400,000 shares $23.12 million -9.7%N/A4.7 $2.46 1/15/202410,410,000 shares $28.84 million +8.3%N/A5.5 $2.77 12/31/20239,610,000 shares $22.58 million +18.4%N/A6.6 $2.35 12/15/20238,120,000 shares $16.40 million -1.2%N/A6.2 $2.02 11/30/20238,220,000 shares $15.29 million -8.2%N/A7 $1.86 11/15/20238,950,000 shares $13.16 million +14.9%N/A8.1 $1.47 10/31/20237,790,000 shares $14.26 million +2.4%N/A8.4 $1.83 10/15/20237,610,000 shares $12.02 million -4.0%N/A8 $1.58 9/30/20237,930,000 shares $14.75 million +0.6%N/A8.4 $1.86 9/15/20237,880,000 shares $15.76 million +6.2%N/A7.5 $2.00 8/31/20237,420,000 shares $16.84 million -12.9%N/A6.9 $2.27 8/15/20238,520,000 shares $19.00 million +2.7%N/A7.8 $2.23 7/31/20238,300,000 shares $21.66 million -2.6%N/A7.1 $2.61 7/15/20238,520,000 shares $21.64 million +0.4%N/A7.2 $2.54 6/30/20238,490,000 shares $22.24 million -5.0%N/A6.5 $2.62 6/15/20238,940,000 shares $24.23 million +13.6%N/A6.7 $2.71 5/31/20237,870,000 shares $20.15 million -5.5%N/A6.2 $2.56 5/15/20238,330,000 shares $23.66 million -1.9%N/A6.3 $2.84 4/30/20238,490,000 shares $19.19 million +6.3%N/A6.9 $2.26$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. 4/15/20237,990,000 shares $17.34 million +2.0%N/A7 $2.17 3/31/20237,830,000 shares $12.76 million -5.4%N/A6.7 $1.63 3/15/20238,280,000 shares $10.76 million +20.9%N/A7.6 $1.30 2/28/20236,850,000 shares $9.45 million +13.4%N/A6.9 $1.38 2/15/20236,040,000 shares $7.61 million -6.9%N/A6.8 $1.26 1/31/20236,490,000 shares $8.05 million +9.1%N/A7.7 $1.24 1/15/20235,950,000 shares $7.62 million +1.9%N/A6.8 $1.28 12/30/20225,840,000 shares $7.77 million +2.5%N/A6.5 $1.33 12/15/20225,700,000 shares $7.64 million -0.7%N/A7.3 $1.34 11/30/20225,740,000 shares $8.61 million -9.5%N/A7 $1.50 11/15/20226,340,000 shares $8.81 million +0.8%N/A7.7 $1.39 10/31/20226,290,000 shares $10.06 million +0.8%N/A7.6 $1.60 10/15/20226,240,000 shares $7.61 million -5.5%N/A7.2 $1.22 9/30/20226,600,000 shares $10.30 million -21.6%N/A8 $1.56 9/15/20228,420,000 shares $15.07 million -8.1%N/A8 $1.79 8/31/20229,160,000 shares $15.30 million -4.8%N/A8.3 $1.67 8/15/20229,620,000 shares $18.18 million -7.1%N/A7.5 $1.89 7/31/202210,350,000 shares $14.70 million +4.9%N/A6.1 $1.42 7/15/20229,870,000 shares $14.11 million -3.3%N/A5.5 $1.43 6/30/202210,210,000 shares $15.72 million +64.7%N/A5.6 $1.54 6/15/20226,200,000 shares $10.91 million -8.3%N/A3.3 $1.76 5/31/20226,760,000 shares $14.94 million +9.0%N/A3.7 $2.21 5/15/20226,200,000 shares $10.60 million +14.6%N/A3.4 $1.71 4/30/20225,410,000 shares $13.20 million +20.2%N/A3.3 $2.44 4/15/20224,500,000 shares $11.03 million +12.8%N/A2.6 $2.45 3/31/20223,990,000 shares $10.21 million -23.4%N/A2.1 $2.56 3/15/20225,210,000 shares $13.91 million -1.7%N/A1.7 $2.67 2/28/20225,300,000 shares $12.61 million -17.3%N/A1.8 $2.38 2/15/20226,410,000 shares $16.47 million -3.5%N/A2.1 $2.57 1/31/20226,640,000 shares $14.01 million +41.6%N/A2.1 $2.11 1/15/20224,690,000 shares $10.41 million +27.5%N/A1.5 $2.22 12/31/20213,680,000 shares $10.78 million +4.3%N/A0 $2.93 12/15/20213,530,000 shares $8.01 million +16.1%N/A1.9 $2.27 11/30/20213,040,000 shares $6.35 million -30.9%N/A1.8 $2.09 11/15/20214,400,000 shares $10.91 million +14.6%N/A2.4 $2.48 10/29/20213,840,000 shares $7.14 million +13.6%N/A1.1 $1.86 10/15/20213,380,000 shares $6.76 million -17.2%N/A1 $2.00 9/30/20214,080,000 shares $10.00 million -5.1%N/A1.2 $2.45 9/15/20214,300,000 shares $10.97 million -12.1%6.6%1.2 $2.55 8/31/20214,890,000 shares $13.50 million +9.9%7.6%1.2 $2.76 8/13/20214,450,000 shares $10.32 million -17.3%6.9%1 $2.32 7/30/20215,380,000 shares $16.52 million +0.6%8.2%1.8 $3.07 7/15/20215,350,000 shares $18.89 million -60.1%8.3%1.8 $3.53 6/30/202113,400,000 shares $54.54 million -13.9%20.7%4.4 $4.07 6/15/202115,570,000 shares $64.46 million +1.8%24.0%5.4 $4.14 5/28/202115,290,000 shares $47.70 million +0.1%23.6%5.2 $3.12 5/14/202115,270,000 shares $48.71 million +14.4%N/A6.4 $3.19 4/30/202113,350,000 shares $51.66 million -1.6%N/A5.3 $3.87 4/15/202113,560,000 shares $55.19 million -1.1%N/A5.2 $4.07 3/31/202113,710,000 shares $57.72 million +29.1%N/A5 $4.21$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. 3/15/202110,620,000 shares $51.08 million +24.8%N/A3.9 $4.81 2/26/20218,510,000 shares $46.08 million +44.5%N/A3.6 $5.42 2/12/20215,890,000 shares $39.05 million +22.0%N/A2.7 $6.63 1/29/20214,830,000 shares $25.16 million -10.6%N/A2.4 $5.21 1/15/20215,400,000 shares $31.00 million +6.3%N/A3.1 $5.74 12/31/20205,080,000 shares $25.96 million -3.8%N/A2.9 $5.11 12/15/20205,280,000 shares $24.50 million -22.8%N/A3.1 $4.64 11/30/20206,840,000 shares $30.99 million -53.8%N/A3.5 $4.53 10/30/202014,500,000 shares $71.34 million -18.0%N/A4.6 $4.92 10/15/202017,680,000 shares $94.94 million +0.9%N/A5.1 $5.37 9/30/202017,530,000 shares $103.95 million +9.5%N/A4.7 $5.93 9/15/202016,010,000 shares $88.86 million -3.7%N/A3.7 $5.55 8/31/202016,620,000 shares $78.11 million +9.2%N/A4.3 $4.70 8/14/202015,220,000 shares $63.77 million +14.6%N/A4.7 $4.19 7/31/202013,280,000 shares $37.98 million +17.8%N/A5.7 $2.86 7/15/202011,270,000 shares $31.89 million +78.3%N/A5.8 $2.83 6/30/20206,320,000 shares $16.81 million +354.7%N/A4.3 $2.66 6/15/20201,390,000 shares $6.27 million -0.7%N/A2.4 $4.51 5/29/20201,400,000 shares $7.49 million -40.2%N/A2.2 $5.35 5/15/20202,340,000 shares $8.85 million +10.4%N/A3.6 $3.78 4/30/20202,120,000 shares $5.72 million +16.5%N/A2.9 $2.70 4/15/20201,820,000 shares $3.20 million +5.2%N/A3 $1.76 3/31/20201,730,000 shares $3.37 million +9.4%N/A3.1 $1.95 3/13/20201,582,100 shares $3.10 million +4.8%7.0%2.6 $1.96 2/28/20201,510,000 shares $2.52 million +18.9%6.6%3 $1.67 2/14/20201,270,000 shares $2.55 million -40.4%5.6%2.9 $2.01 1/31/20202,130,000 shares $8.20 million -2.3%9.3%8.8 $3.85 1/15/20202,180,000 shares $9.44 million +3.8%9.6%10.2 $4.33 XERS Short Interest - Frequently Asked Questions What is Xeris Biopharma's current short interest? Short interest is the volume of Xeris Biopharma shares that have been sold short but have not yet been covered or closed out. As of December 15th, traders have sold 9,520,000 shares of XERS short. Learn More on Xeris Biopharma's current short interest. What is a good short interest ratio for Xeris Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XERS shares currently have a short interest ratio of 6.0. Learn More on Xeris Biopharma's short interest ratio. Is Xeris Biopharma's short interest increasing or decreasing? Xeris Biopharma saw a decline in short interest in the month of December. As of December 15th, there was short interest totaling 9,520,000 shares, a decline of 3.9% from the previous total of 9,910,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Xeris Biopharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Xeris Biopharma: Apogee Therapeutics, Inc. (21.96%), Recursion Pharmaceuticals, Inc. (20.74%), Mirum Pharmaceuticals, Inc. (14.25%), Akero Therapeutics, Inc. (4.73%), Harmony Biosciences Holdings, Inc. (13.44%), ImmunityBio, Inc. (6.37%), Wave Life Sciences Ltd. (4.62%), Agios Pharmaceuticals, Inc. (9.29%), Disc Medicine, Inc. (10.61%), Galapagos NV (2.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Xeris Biopharma stock? Short selling XERS is an investing strategy that aims to generate trading profit from Xeris Biopharma as its price is falling. XERS shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xeris Biopharma? A short squeeze for Xeris Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XERS, which in turn drives the price of the stock up even further. How often is Xeris Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XERS, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies APGE Short Interest Data RXRX Short Interest Data MIRM Short Interest Data AKRO Short Interest Data HRMY Short Interest Data IBRX Short Interest Data WVE Short Interest Data AGIO Short Interest Data IRON Short Interest Data GLPG Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XERS) was last updated on 1/2/2025 by MarketBeat.com Staff From Our Partners3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Next Big Thing in AI: Musk’s Secret SupplierWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredDeadline Approaching! A new system to collect up to $4,243 in monthly dividendsI've just released updated details on a new system for collecting steady dividend income each and every month....Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xeris Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xeris Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
